Prevalence of depression symptoms and serum levels of interleukin-6 in hemodialysis patients

Psychiatry and Clinical Neurosciences

Volumn 68, Issue 4, 2014, Pages 275-282

  Knuth, Berenice ^a   Radtke, Vinícius ^a   Rocha, Pablo ^a   Da Silva, Kátia Sulenir ^a   Dalsõglio, Fabiana ^a   Gazal, Marta ^a   Jansen, Karen ^a   Souza, Diogo Onofre ^c   Portela, Luis Valmor ^c   Kaster, Manuella ^a   Oses, Jean Pierre ^a,b  

^a Laboratory of Clinical Neuroscience Postgraduate Program in Health and Behavior Center for Life Sciences and Health   (Brazil)

^b CATHOLIC UNIVERSITY OF PELOTAS   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

biochemical markers; depressive symptoms; end stage renal disease; hemodialysis; interleukin 6

Indexed keywords

ALBUMIN; ANTIDEPRESSANT AGENT; ANTIEMETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFLAMMATORY AGENT; ANXIOLYTIC AGENT; CALCITRIOL; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; POTASSIUM; PROTEIN; RECOMBINANT ERYTHROPOIETIN; SEVELAMER; TRIACYLGLYCEROL; UREA;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BECK DEPRESSION INVENTORY; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE ASSOCIATION; END STAGE RENAL DISEASE; FEMALE; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; POTASSIUM BLOOD LEVEL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL; ADOLESCENT; AGED; BLOOD; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; PREVALENCE; PSYCHOLOGY; RENAL REPLACEMENT THERAPY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HUMANS; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREVALENCE; RENAL DIALYSIS; YOUNG ADULT;

EID: 84898740221     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/pcn.12130     Document Type: Article

References (24)

1. Kimmel PL,. Psychosocial factors in adult end-stage renal disease patients treated with hemodialysis: Correlates and outcomes. Am. J. Kidney Dis. 2000; 35: S132-S140.
2. Chilcot J, Wellsted D, Da Silva-Gane M, Farrington K,. Depression on dialysis. Nephron Clin. Pract. 2008; 108: c256-c264.
3. Cohen SD, Norris L, Acquaviva K, Peterson RA, Kimmel PL,. Screening, diagnosis, and treatment of depression in patients with end-stage renal disease. Clin. J. Am. Soc. Nephrol. 2007; 2: 1332-1342.
4. Hung KC, Wu CC, Chen HS, et al. Serum IL-6, albumin and co-morbidities are closely correlated with symptoms of depression in patients on maintenance haemodialysis. Nephrol. Dial. Transplant. 2011; 26: 658-664.
5. Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol. Psychiatry 2010; 67: 446-457.
6. Mikova O, Yakimova R, Bosmans E, Kenis G, Maes M,. Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis. Eur. Neuropsychopharmacol. 2001; 11: 203-208.
7. Tuglu C, Kara SH, Caliyurt O, Vardar E, Abay E,. Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology (Berl) 2003; 170: 429-433.
8. Loftis JM, Huckans M, Morasco BJ,. Neuroimmune mechanisms of cytokine-induced depression: Current theories and novel treatment strategies. Neurobiol. Dis. 2010; 37: 519-533.
9. Marques AH, Cizza G, Sternberg E,. [Brain-immune interactions and implications in psychiatric disorders]. Rev. Bras. Psiquiatr. 2007; 29: S27-S32.
10. Bossola M, Ciciarelli C, Di Stasio E, et al. Correlates of symptoms of depression and anxiety in chronic hemodialysis patients. Gen. Hosp. Psychiatry 2009; 32: 125-131.
11. Sonikian M, Metaxaki P, Papavasileiou D, et al. Effects of interleukin-6 on depression risk in dialysis patients. Am. J. Nephrol. 2010; 31: 303-308.
12. Dervisoglu E, Kir HM, Kalender B, Eraldemir C, Caglayan C,. Depressive symptoms and proinflammatory cytokine levels in chronic renal failure patients. Nephron Clin. Pract. 2008; 108: c272-c277.
13. Buur T,. Two-sample hemodialysis urea kinetic modeling: Validation of the method. Nephron 1995; 69: 49-53.
14. Gorenstein C, Andrade L,. Validation of a Portuguese version of the Beck Depression Inventory and the State-Trait Anxiety Inventory in Brazilian subjects. Braz. J. Med. Biol. Res. 1996; 29: 453-457.
15. Kimmel PL, Cukor D, Cohen SD, Peterson RA,. Depression in end-stage renal disease patients: A critical review. Adv. Chronic Kidney Dis. 2007; 14: 328-334.
16. Kimmel PL,. Depression in patients with chronic renal disease: Where are we going? J. Ren. Nutr. 2008; 18: 99-103.
17. Andrade CP, Cruz MC, Urrutia M, et al. Evaluation of depressive symptoms in patients with chronic renal failure. J. Nephrol. 2010; 23: 168-174.
18. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP,. The pathophysiologic roles of interleukin-6 in human disease. Ann. Intern. Med. 1998; 128: 127-137.
19. Yirmiya R, Pollak Y, Morag M, et al. Illness, cytokines, and depression. Ann. N. Y. Acad. Sci. 2000; 917: 478-487.
20. Capuron L, Gumnick JF, Musselman DL, et al. Neurobehavioral effects of interferon-alpha in cancer patients: Phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 2002; 26: 643-652.
21. Schiepers OJ, Wichers MC, Maes M,. Cytokines and major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005; 29: 201-217.
22. Koo JR, Yoon JW, Kim SG, et al. Association of depression with malnutrition in chronic hemodialysis patients. Am. J. Kidney Dis. 2003; 41: 1037-1042.
23. Daugirdas JT, Blake P, Ing TS,. Handbook of Dialysis. Lippincott Williams and Wilkins, Philadelphia, 2007.
24. Zyoud SH, Awang R, Syed Sulaiman SA, Al-jabi SW,. High prevalence of hypokalemia after acute acetaminophen overdose: Impact of psychiatric illness. Hum. Exp. Toxicol. 2010; 29: 773-778. Nível Superior